Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 207
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Two New Zealand Psychiatrists Approved to Prescribe MDMA for PTSD
Pα+ Library: Psychedelic REMS
The Best Psychedelic Education Does Not Look Psychedelic
Pα+ Psychedelic Bulletin #230: Pharma Ramps Up Ad Spend on Psychedelic Keywords; ARPA-H’s Ibogaine Funding; Psychedelics in Medicaid?
A Closer Look at Definium’s Phase 3 LSD for GAD Readout
PharmaTher Granted FDA Orphan Drug Designation for Ketamine to Treat Status...
Mydecine Submits Pre-Investigational New Drug Briefing Package to the FDA for...
IntelGenx Receives Third Loan Tranche from atai
Field Trip Health Ltd. Schedules Third Fiscal Quarter 2022 Financial Results...
Psychedelic or Not: Of Mice, 5-HT2A Agonists, and Head Shakes
PT289 – Payton Nyquvest – Shifting the Mindset on Pain, Psychedelics,...
Psychedelic Bulletin: MDMA Fast-Tracked in UK; FDA Clears MindMed LSD Trial;...
Red Light Holland’s Partner CCrest Laboratories Approved By Health Canada to...
PT288 – Annie & Michael Mithoefer – Vital Psychedelic Conversations
Numinus Identified as a Licensed Psilocybin Supplier by Health Canada
Load more